Business Description
Advanced Enzyme Technologies Ltd
ISIN : INE837H01020
Compare
Compare
Traded in other countries / regions
ADVENZYMES.India IPO Date
2016-08-01Description
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The Company operates only in one business segment viz. manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.13 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.17 | |||||
| Interest Coverage | 65.32 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 18.32 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7 | |||||
| 3-Year EBITDA Growth Rate | -5 | |||||
| 3-Year EPS without NRI Growth Rate | -4.8 | |||||
| 3-Year FCF Growth Rate | 4.2 | |||||
| 3-Year Book Growth Rate | 13.7 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 88.92 | |||||
| 9-Day RSI | 76.69 | |||||
| 14-Day RSI | 67.01 | |||||
| 6-1 Month Momentum % | 19.11 | |||||
| 12-1 Month Momentum % | 38.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.42 | |||||
| Quick Ratio | 6.87 | |||||
| Cash Ratio | 5.39 | |||||
| Days Inventory | 303.45 | |||||
| Days Sales Outstanding | 62.95 | |||||
| Days Payable | 57.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.28 | |||||
| Dividend Payout Ratio | 0.39 | |||||
| 3-Year Dividend Growth Rate | 18.6 | |||||
| Forward Dividend Yield % | 1.53 | |||||
| 5-Year Yield-on-Cost % | 3.22 | |||||
| Shareholder Yield % | 1.37 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.59 | |||||
| Operating Margin % | 29.07 | |||||
| Net Margin % | 22.68 | |||||
| FCF Margin % | 16.9 | |||||
| ROE % | 11.28 | |||||
| ROA % | 9.75 | |||||
| ROIC % | 14.02 | |||||
| ROC (Joel Greenblatt) % | 41.05 | |||||
| ROCE % | 14.54 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 30.15 | |||||
| PE Ratio without NRI | 28.69 | |||||
| Shiller PE Ratio | 35.37 | |||||
| Price-to-Owner-Earnings | 34.31 | |||||
| PEG Ratio | 10.63 | |||||
| PS Ratio | 6.84 | |||||
| PB Ratio | 3.32 | |||||
| Price-to-Tangible-Book | 5.06 | |||||
| Price-to-Free-Cash-Flow | 40.52 | |||||
| Price-to-Operating-Cash-Flow | 29.5 | |||||
| EV-to-EBIT | 20.47 | |||||
| EV-to-EBITDA | 17.37 | |||||
| EV-to-Revenue | 6.53 | |||||
| EV-to-FCF | 35.85 | |||||
| Price-to-Projected-FCF | 1.98 | |||||
| Price-to-DCF (Earnings Based) | 2.16 | |||||
| Price-to-DCF (FCF Based) | 2.07 | |||||
| Price-to-Graham-Number | 2.74 | |||||
| Price-to-Net-Current-Asset-Value | 8.13 | |||||
| Price-to-Net-Cash | 15.93 | |||||
| Earnings Yield (Greenblatt) % | 4.89 | |||||
| FCF Yield % | 2.32 | |||||
| Forward Rate of Return (Yacktman) % | 5.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Advanced Enzyme Technologies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 6,045.08 | ||
| EPS (TTM) (₹) | 12.28 | ||
| Beta | 0.66 | ||
| Volatility % | 27.1 | ||
| 14-Day RSI | 67.01 | ||
| 14-Day ATR (₹) | 12.765049 | ||
| 20-Day SMA (₹) | 367.155 | ||
| 12-1 Month Momentum % | 38.58 | ||
| 52-Week Range (₹) | 252.05 - 425.1 | ||
| Shares Outstanding (Mil) | 111.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Advanced Enzyme Technologies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Advanced Enzyme Technologies Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Advanced Enzyme Technologies Ltd Frequently Asked Questions
What is Advanced Enzyme Technologies Ltd(BOM:540025)'s stock price today?
The current price of BOM:540025 is ₹391.50. The 52 week high of BOM:540025 is ₹425.10 and 52 week low is ₹252.05.
When is next earnings date of Advanced Enzyme Technologies Ltd(BOM:540025)?
The next earnings date of Advanced Enzyme Technologies Ltd(BOM:540025) is 2024-05-31 Est..
Does Advanced Enzyme Technologies Ltd(BOM:540025) pay dividends? If so, how much?
The Dividend Yield %  of Advanced Enzyme Technologies Ltd(BOM:540025) is 1.28% (As of Today), Highest Dividend Payout Ratio of Advanced Enzyme Technologies Ltd(BOM:540025) was 0.39. The lowest was 0.05. And the median was 0.05. The  Forward Dividend Yield % of Advanced Enzyme Technologies Ltd(BOM:540025) is 1.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers